If the safety and modest efficacy data from the published trials translate to our patient population, it would give us a tool that acts directly on fat cell metabolism rather than appetite, with a side effect profile that appears extremely well-tolerated
This latter benefit may make it possible to more adequately treat psychiatric conditions, which are notoriously difficult to treat, in part because patients often discontinue their medications secondary to severe side effects
Theyre discussed in fitness circles, promoted in recovery forums, and even mentioned by some clinics as part of so-called peptide therapy. But heres the reality most people never hear clearly: There is no FDA-recognized prescription pathway for BPC-157, TB-500, or most non-FDA-approved peptides
Subsequent work by Pickart and Margolina identified clusters of affected genes spanning DNA repair, antioxidant defense, ubiquitinproteasome activity, anti-inflammatory signaling, and tissue remodeling [2]